- Home
- BOF vs CASI Comparison
BOF vs CASI Comparison
Compare BOF & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- CASI
- Stock Information
- Founded
- BOF 2017
- CASI 1991
- Country
- BOF United States
- CASI China
- Employees
- BOF N/A
- CASI N/A
- Industry
- BOF Packaged Foods
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- BOF Consumer Staples
- CASI Health Care
- Exchange
- BOF Nasdaq
- CASI Nasdaq
- Market Cap
- BOF 21.2M
- CASI 20.5M
- IPO Year
- BOF 2023
- CASI 1996
- Fundamental
- Price
- BOF $2.69
- CASI $1.40
- Analyst Decision
- BOF
- CASI Strong Buy
- Analyst Count
- BOF 0
- CASI 1
- Target Price
- BOF N/A
- CASI $4.00
- AVG Volume (30 Days)
- BOF 103.4K
- CASI 313.5K
- Earning Date
- BOF 08-13-2025
- CASI 08-15-2025
- Dividend Yield
- BOF N/A
- CASI N/A
- EPS Growth
- BOF N/A
- CASI N/A
- EPS
- BOF N/A
- CASI N/A
- Revenue
- BOF $8,242,843.00
- CASI $31,368,000.00
- Revenue This Year
- BOF N/A
- CASI N/A
- Revenue Next Year
- BOF N/A
- CASI N/A
- P/E Ratio
- BOF N/A
- CASI N/A
- Revenue Growth
- BOF 96.47
- CASI 8.39
- 52 Week Low
- BOF $0.61
- CASI $1.09
- 52 Week High
- BOF $4.11
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- BOF 62.25
- CASI 44.81
- Support Level
- BOF $2.46
- CASI $1.23
- Resistance Level
- BOF $2.87
- CASI $1.50
- Average True Range (ATR)
- BOF 0.18
- CASI 0.12
- MACD
- BOF 0.04
- CASI 0.03
- Stochastic Oscillator
- BOF 79.78
- CASI 78.05
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.